News

Does the 23andMe Acquisition Make Regeneron a Buy Now?
Regeneron agreed to acquire 23andMe for $256 million. At its peak, 23andMe's market value swelled to $5.8 billion. Recently, ...
Pharmabiz58m
Predictive Oncology breakthrough coincides with Regeneron Pharma’s acquisition of 23andMe for $256 million: Artificial intelligence meets genomics
Pittsburgh, Pennsylvania Saturday, May 24, 2025, 15:00 Hrs [IST] ...